TowerBrook, a New York and London-based international investment firm, agreed to invest a majority stake in Demakes, a manufacturer of value-added protein products. Financial terms were not disclosed. “We are thrilled to partner with the Demakes family to continue to build on the company’s legacy. Over the last century, Demakes has consistently delivered an innovative portfolio of products that resonate with US consumers’ increasing demand for convenient, health-conscious choices,” Michael Recht, TowerBrook Managing Director.